Clinical trial
An Extension Study MRI/US Fusion Imaging and Biopsy in Combination With…
NCT04240639 · Nanospectra Biosciences, Inc., Industry · Unknown status
Key facts
| NCT number | NCT04240639 |
|---|---|
| Title | An Extension Study MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue |
| Official title | A Study of MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue |
| Lead sponsor | Nanospectra Biosciences, Inc., Industry |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Neoplasms of the Prostate |
| Intervention type | Device |
| Interventions | AuroShell particle infusion |
| Enrollment | 60 |
| Start date | Jan 30, 2020 |
| Primary completion | Dec 31, 2022 |
| Completion | Jun 1, 2023 |
| First posted | Jan 27, 2020 |
| Last update posted | May 18, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: